FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 184 filers reported holding FIBROGEN INC in Q2 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,008 | -71.3% | 9,280 | -10.2% | 0.00% | -71.4% |
| Q2 2023 | $27,891 | -89.0% | 10,330 | -23.7% | 0.01% | -89.6% |
| Q1 2023 | $252,563 | +16.5% | 13,535 | 0.0% | 0.13% | +7.2% |
| Q4 2022 | $216,831 | -17.9% | 13,535 | -33.3% | 0.12% | -19.4% |
| Q3 2022 | $264,000 | +34.7% | 20,285 | +9.4% | 0.16% | +27.0% |
| Q2 2022 | $196,000 | -12.1% | 18,535 | 0.0% | 0.12% | +10.9% |
| Q1 2022 | $223,000 | -14.6% | 18,535 | 0.0% | 0.11% | -10.6% |
| Q4 2021 | $261,000 | +26000.0% | 18,535 | +61683.3% | 0.12% | +12200.0% |
| Q3 2021 | $1,000 | 0.0% | 30 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,000 | 0.0% | 30 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $1,000 | – | 30 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 605,713 | $9,703,522 | 5.73% |
| ARMISTICE CAPITAL, LLC | 3,864,000 | $61,901,280 | 1.08% |
| Logos Global Management LP | 525,000 | $8,410,500 | 0.98% |
| 5AM Venture Management, LLC | 225,583 | $3,613,840 | 0.97% |
| Intercontinental Wealth Advisors, LLC | 191,300 | $3,064,626 | 0.91% |
| BHK Investment Advisors, LLC | 87,550 | $1,402,551 | 0.79% |
| Integral Health Asset Management, LLC | 175,000 | $2,803,500 | 0.59% |
| Nan Fung Group Holdings Ltd | 34,106 | $546,378 | 0.38% |
| Soleus Capital Management, L.P. | 113,463 | $1,817,677 | 0.26% |
| Point72 Asset Management, L.P. | 4,781,645 | $76,601,953 | 0.26% |